Bio
Angela Zhou serves as the Executive Editor of CAS Insights and the Lead Scientist in Life Sciences at CAS. Dr. Zhou earned her Ph.D. in Molecular Pharmacology and Toxicology from the University of Southern California, followed by postdoctoral training in cell biology at Johns Hopkins School of Medicine and specialized research in cancer therapeutics at Harvard Medical School.
Prior to joining CAS, Dr. Zhou held faculty positions at Missouri State University and Denison University, concentrating on teaching and research of cancer biology, cell signaling and biochemistry. At CAS, she leads a multidisciplinary team of research and data scientists who leverage comprehensive scientific databases. Dr. Zhou's unique blend of scientific expertise and data analytics leadership enables her team to deliver strategic intelligence, helping organizations navigate emerging trends and opportunities across chemistry, life sciences, and materials science.
Extremófilos: como a vida nos limites impulsiona inovações biomédicas e industriais
Desextinção molecular abre possibilidades para novos antibióticos
O futuro da administração de medicamentos à base de lipídios
Friend, not foe: Harnessing the gut microbiome for health benefits
ACE2: Targeting a potentially important receptor in disease pathogenesis
